Trade
Group Sites
Premia
Business Partners
Wealth
FLAME
Property Solutions
IIFL Finance
IIFL MF
IIFL Associates
About IIFl
Contact IIFl
Investor Relations
We're HIRING
FEEDBACK
Register
Login
Sensex
19,704.33
+30.00
0.15%
Nifty
5,983.55
+16.50
0.28%
Commodity Ideas
Stock Ideas
IIFL Live
Customer Service
Corporate News
IIFL
Quote
News
Quotes
View all
MF
View all
Insurance
View all
Commodity
View all
No Result found
Home
Markets
Equities
Market Statistics
Charts
Market Map
Derivatives
Commodity
IPO
Companies
News
Overview
Top
Business
Corporate
Equities
Commodity
Currency
MF
Insurance
IPO
Economy
Global
M&A
Gold
PR Newswire
Dow Jones
Business Wire
Research & Ideas
Overview
Recommendations
Sectors
Market Analysis
Leader Speak
Featured Reports
Sector Indices
Articles
In Focus
Calendar
Economy
Mutual Funds
Fund Snapshot
Fund Houses
Equity Funds
Debt Funds
Balanced Funds
ETFs
NFO Updates
Dividend Tracker
Fund Manager Speak
Apply Online
Discuss
Discussions
Polls
Videos
Chat With Experts
Live TV
Personal Finance
Overview
Insurance
NRI Corner
Loans
Calculators
Articles
Union Budget
Railway Budget
Data Monitor
Blog
Portfolio
Company Snapshot
Research
India Infoline Research
MF Investments
FII Investments
Bulk Deals
Block Deals
Daily Share Prices
Monthly Share Prices
Fundamentals
Profit & Loss
Balance Sheet
Cash Flow
Key Ratios
Management
Discussions
Share Holding Pattern
Equity Capital
Structure
Director's Report
Auditor's Report
Quarterly Results
Half Yearly Results
Nine Monthly Results
Annual Results
Background
Key Executives
Board of Directors
Meeting Schedule
Stock history
Company Profile
Products & Services
Raw Materials
Finished Goods
Bankers
Auditors
Location
News
Company News
Sector News
Corporate
Announcements
IndiaInfoline
Markets
Companies
Astrazeneca Pharma India Ltd
BSE: 506820 | NSE: ASTRAZEN | ISIN: INE203A01020
Market Cap: [Rs.Cr.] 1,730 | Face Value: [Rs.] 2
Industry: Pharmaceuticals - Multinational
Discuss this stock
Company News
May 24, 2013
18:00
AstraZeneca promoters to sell 3.75mn shares via OFS on May 28h
May 22, 2013
11:15
AstraZeneca Pharma drops as company skips dividend on poor financials
May 16, 2013
12:02
AstraZeneca Pharma India - Board to consider Dividend
May 06, 2013
15:28
AstraZeneca Pharma in demand
May 03, 2013
12:36
AstraZeneca Pharma India - Board Meeting
10:30
AstraZeneca Pharma India Director Resigns
09:43
Astrazeneca Pharma India reports net loss of Rs 18.58 crore in the March 2013 quarter
Apr 03, 2013
14:54
AstraZeneca’s biologics unit, acquires AlphaCore Pharma
Mar 19, 2013
13:21
AstraZeneca Pharma bucks trend on bargain hunting
Mar 06, 2013
09:43
AstraZeneca Pharma slumps as promoter to cut stake
Mar 05, 2013
17:29
Astrazeneca Pharma India reports net loss of Rs 17.70 crore in the December 2012 quarter
Feb 12, 2013
13:46
AstraZeneca Pharma reverses 10-day 17.08% slide on bargain hunting
Feb 11, 2013
14:15
AstraZeneca Pharma off 12.1% in 3 days after poor Q3 results
Feb 07, 2013
11:21
AstraZeneca Pharma hits 52-week low on dismal Q3 show
Feb 06, 2013
16:43
AstraZeneca Pharma India appoints whole-time director
Prev
Next
India Infoline Research
Company
|
Sectors
No Related Research Found
Related News
Company
|
Sector
|
Latest
24-May-13
AstraZeneca promoters to sell 3.75mn shares via OFS on May 28h
22-May-13
AstraZeneca Pharma drops as company skips dividend on poor financials
16-May-13
AstraZeneca Pharma India - Board to consider Dividend
06-May-13
AstraZeneca Pharma in demand
03-May-13
AstraZeneca Pharma India - Board Meeting
03-May-13
AstraZeneca Pharma India Director Resigns
More News
Peer Comparison
Company
Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Glaxosmit Pharma
19,207.00
29.02
9.56
18.86
34.3
45.2
0.00
Sanofi India
5,688.41
31.44
4.77
13.73
15.4
22.5
0.00
Pfizer
3,126.19
15.17
1.83
9.41
15.0
22.1
0.00
Abbott India
3,070.09
18.49
4.75
12.08
24.3
34.8
0.00
Fres.Kabi Onco.
1,976.71
22.04
3.34
22.38
3.5
5.4
0.42
Wyeth
1,771.48
13.62
3.09
7.61
33.4
45.1
0.01
Astrazeneca Phar
1,729.88
0.00
17.34
140.28
10.7
15.2
0.03
Novartis India
1,597.68
13.34
1.77
10.43
20.0
28.8
0.00
Merck
1,079.08
13.49
2.23
7.04
17.5
25.5
0.00
Fulford (India)
247.65
0.00
1.71
0.00
-3.4
-4.7
0.00
Organon (India)
159.14
0.00
0.98
0.00
15.3
22.8
0.00
Futures & Options Quote
Future
|
Option
Expiry Date
Stock not available in F&O
NA
Instrument:
NA
Expiry Date:
NA
Strike Price:
NA
Open Price:
NA
Average Price:
NA
No. of Contracts Traded:
NA
Open Interest:
NA
Underlying:
NA
Option Type:
NA
Market Lot:
NA
Previous Close:
NA
Day’s High | Low:
NA | NA
Turnover (Cr.):
NA
Open Int. Change:
NA | NA
View detailed F& O quotes >>
Key Information
Key Executives:
D E Udwadia , Chairman
K S Shah , Director
Ian Brimicombe , Director
Ruby Lau , Whole-time Director
Company Head Office / Quarters:
Avishkar Off Bellary Road,
P B No 2483 Hebbal,
Bangalore,
Karnataka-560024
Phone : 91-80-23622020-27
Fax : 91-80-23622015
E-mail :
comp.secy@astrazeneca.com
Web :
http://www.astrazenecaindia.com
Registrars:
Integrated Enterprises (I) Ltd
No. 30 Ramana Resid.
4th Cross Sampige Rd
Malleswaram
Bangalore - 560003
Fund Holding
Mutual Funds
|
Fll
Scheme Name
No. of Shares
Goldman Sachs CNX 500 Fund (G)
62
Detailed List
Calendar
May-2013
M
T
W
T
F
S
S
20
21
22
23
24
25
26
IPO
Issue Open :
India Finsec
View full month IPO calendar
Economic Events
Bank of Japan April 26 meeting minutes
BOJ Governor Kuroda Speech in Tokyo
View full month Economic Events calendar
Results
No result today
View full month Results calendar